SEATTLE: A recent published study suggests that the currently held assumptions about the pathogenic mutation process associated with the onset of inherited or familial Alzheimer’s disease (FAD) may be inaccurate.

The study aimed to address the important unanswered questions as to whether a specific mutation Read More »

DENVER: A drug widely used for treating epilepsy could also slow the onset of dementia, a study has found.

The drug, Levetiracetam, could be used to treat dementia as well as epilepsy.
Researchers have discovered it calms “hyperactivity” in the brain linked with Alzheimer’s.

Full

NEW YORK: A recent study revealed that heart function is an important risk factor in the development of dementia and Alzheimer’s disease.

Cross-sectional epidemiological and clinical studies have been suggesting an association between lower cardiac index and abnormal brain aging, including smaller brain volumes, increased Read More »

CHICAGO: Researchers have provided the first evidence that a simple blood test could be developed to confirm the presence of beta amyloid proteins in the brain, which is a hallmark of Alzheimer’s disease.

“Blood-based biomarkers would have the important advantage

Full story covered in the